Metrics as of 10/13/2026, 06:38 PM (Berlin time), refresh in progress.
BioPharma Credit PLC
Operating as an investment trust since its founding in 2016 in Exeter, United Kingdom, BioPharma Credit PLC concentrates its investments on interest-bearing debt assets. These assets are financially backed by royalties or other revenue derived from the sales of established life sciences products.
1D
+0.7%
1W
+0.5%
1M
+2.2%
6M
+5.4%
YTD
+8.4%
1Y
+6.3%
2Y
+10.1%
5Y
+1.8%
10Y
–
Next earnings date
No date known
Volatility around earnings
~37% weaker price swings than usual
Pattern detected by the Market Jury detector vdouble-bottom-top-v1.0 on 15/10/26. Not a buy or sell signal.Beta
What does this mean?
Double bottom
BullishThe price bounced off a similar low twice, with a rally in between. This W-shaped pattern is a classic reversal signal from a downtrend into an uptrend.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
P/E
10.18
P/B
0.96
EV/EBITDA
17.86
RETURN ON EQUITY
4.4%
NET MARGIN
87.7%
DEBT/EQUITY
0
DIVIDEND YIELD
8.7%
AS OF
30/06/2026
FREE FLOAT
98.3%
FLOAT SHARES
1,125,219,019
AVG. DAILY VOLUME (30D)
184,012
BioPharma Credit PLC is a company in the Financial Services sector, Asset Management industry, headquartered in United Kingdom.
The CEO is Pedro Gonzalez de Cosio, the company employs around 15 people.
The IPO was on 05/10/2021; the stock trades on LSE under the ticker BPCP.L.
Around past earnings, price swings were roughly -37% stronger than usual.
Yes. The last dividend was £1.33 per share, ex-date 08/10/2026, paid on 06/11/2026.
The dividend yield is 8.7% (as of 30/06/2026).
Comparable stocks include Schroders, Man Group, International Public Partnerships, Greencoat UK Wind, IntegraFin Holdings, Molten Ventures, GCP Infrastructure Investments and Foresight Environmental Infra Ord.
Clicking "Analyze stock" lets five strategies assess BioPharma Credit against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.